This week, we’re delighted to be joined by Lana Denysyk, Head of RWD Assets at Novo Nordisk.

During this conversation, Lana shares how real-world data is used in biotech, diving into how it can help clinicians understand patient experiences outside clinical trials. Lana also discusses the challenges in acquiring and utilising real-world data, the importance of having a centralised team to manage it, and emerging data types like patient-reported outcomes and health equity data. 

Data in Biotech is a fortnightly podcast exploring how companies leverage data innovation in life sciences.

Discussed: 

[1:08] Lana talks about her career to date, from public health graduate to head of a real-world data department at Nova Nordisk. 

[3:55] Ross and Lana break down exactly what real-world data means and how biotech organisations use it. 

[7:03] Lana outlines that RWD is part of a diverse data ecosystem in organizations and why it's crucial to understand which data type best suits specific research questions to avoid silos and maximize data utilization. 

[8:40] Lana gives examples of the types of stakeholder groups that have research questions where RWD is helpful. 

[11:54] Lana walks through how she thinks about scoping a request for RWD and understanding the limitations and applicability of the data. 

[17:36] Ross and Lana discuss the role of RWD professionals in facilitating broader access to data through platforms and tools for non-data scientists. 

[19:33] Lana highlights why standardizing real-world data management processes, despite the diversity in data types, is crucial for efficiently integrating new data into an organization and what this process looks like. 

[21:31] Lana discusses the role of GDPR and HIPAA and its impact on RWD. 

[23:52] Lana discusses real-world data strategy in pharma, highlighting the importance of assessing data adequacy, employee training, and educating all staff on data capabilities and limitations for effective future use. 

[29:10] Lana shares her excitement about emerging real-world data sets beyond traditional claims and EMR sources in pharma,

[32:30] Lana lists some resources people can use to stay up-to-date on the application of RWD in biotech.

---

If you’re a biotech company struggling to unlock a data challenge, CorrDyn can help.

Whether you need to supplement existing technology teams with specialist expertise or launch a data program that lays the groundwork for future internal hires, you can partner with Corrdyn to unlock the potential of your business data - today. 

Visit connect.corrdyn.com/biotech to learn more.

This week, we’re delighted to be joined by Cody Schiffer, Associate Director, Machine Learning at SMPA - a biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need,

During this conversation, Cody and Ross discuss the construction, maintenance, and application of a knowledge graphic in biopharma, including how to integrate structured and unstructured data to support tasks like literature searches, competitive intelligence and drug discovery and the challenges in keeping a knowledge graph updated with new, real-time information. 

Data in Biotech is a fortnightly podcast exploring how companies leverage data innovation in life sciences.

Discussed:

[1:09] Cody shares his background and career to date.

[2:43] Cody outlines how SMPA leverages data science to support its pipeline of investigational assets in healthcare.

[7:36] Cody explains how his team approaches helping scientists better understand scientific literature.

[12:44] Cody explains how the SMPA knowledge graph was constructed and how it is updated over time.

[18:13] Cody discusses how his team incorporates unstructured data in the knowledge graph.

[23:05] Cody explains how they apply weighting to the information that is gathered and ultimately fed into the knowledge graph.

[28:16] Cody shares the biggest lessons he has learned from building and maintaining the knowledge graph.

[34:48] Cody explains how he and SMPA view the build versus buy question when developing internal tools.

[38:47] Cody shares his thoughts on what the future holds for his team and the tools they are building internally.

---

If you’re a biotech company struggling to unlock a data challenge, CorrDyn can help.

Whether you need to supplement existing technology teams with specialist expertise or launch a data program that lays the groundwork for future internal hires, you can partner with Corrdyn to unlock the potential of your business data - today. 

Visit connect.corrdyn.com/biotech to learn more.

This week, we’re delighted to be joined by Vera Mucaj, Chief Scientific Officer at Datavant, a data logistics company for healthcare.

During the interview, Vera shares how the organization helps companies overcome issues of data fragmentation and availability, which ultimately leads to better decision-making in healthcare, the importance of connecting clinical trial data with real-world data to improve research outcomes and the challenges of semantic interoperability in data sets.

Data in Biotech is a fortnightly podcast exploring how companies leverage data innovation in life sciences.

Discussed:

[1:06] Vera introduces herself, explains her role, and explains what drove her to join the scientific field.

[4:00] Vera outlines the challenges that Datavant customers face in the acquisition and sharing of medical data.

[8:49] Vera unpacks the role Datavant plays in enabling healthcare organizations to produce and consume data to answer important scientific questions.

[12:21] Vera addresses the problem of security around data assets and how the company helps producers tackle the risk of the potential de-identification of sensitive patient data.

[15:27] Vera explains the most common use cases of the Datavant platform and the value that can be unlocked by consumers of the platform.

[22:10] Vera outlines Datavant's business model.

[27:06] Vera talks about how Datavant is leveraging AI to generate, analyze and create imputations of data sets.

[31:09] Vera discusses the regulatory and cultural barriers to making data available in healthcare.

[38:53] Vera shares her thoughts on semantic interoperability between data sets.

[44:31] Vera shares the resources that she follows to better understand the work of Datavant.

---

If you’re a biotech company struggling to unlock a data challenge, CorrDyn can help.

Whether you need to supplement existing technology teams with specialist expertise or launch a data program that lays the groundwork for future internal hires, you can partner with Corrdyn to unlock the potential of your business data - today. 

Visit connect.corrdyn.com/biotech to learn more.

Data in Biotech is a fortnightly podcast exploring how companies leverage data innovation in life sciences.

This week, we’re delighted to be joined by James Winegar, CEO of CorrDyn, a data-driven technology consultancy that helps some of the largest biotechnology manufacturers in the US make smarter strategic decisions by unlocking the value of their data.

In this conversation, James and Ross discuss the application of machine learning in biotech manufacturing quality control, their work in providing a custom oligo manufacturer with a data analysis system to track whether certain manufacturing events are anomalous or part of regular operations, and how trust issues between internal teams can lead to conflict, misunderstandings, and ultimately failure to deliver ROI. 

---

CorrDyn is the proud producer of Data in Biotech.

---

If you’re a biotech company struggling to unlock a data challenge, CorrDyn can help.

Whether you need to supplement existing technology teams with specialist expertise or launch a data program that lays the groundwork for future internal hires, you can partner with Corrdyn to unlock the potential of your business data - today. 

Visit connect.corrdyn.com/biotech to learn more.

Data in Biotech is a fortnightly podcast exploring how companies leverage data innovation in life sciences. 

This week, we’re delighted to be joined by Harry Rickerby, Co-founder of Briefly Bio, a groundbreaking platform he's developing to streamline experimental design in life sciences using large language models (LLMs).

Host Ross Katz speaks with Harry about how LLMs are used to facilitate experiment protocol structuring in the platform, the limitations of LLMs in scientific fields, how we can improve collaboration, consistency, and reproducibility in biotech, and how metadata is generated within the experimental design process while interacting with an LLM.

---

If you’re a biotech company struggling to unlock a data challenge, CorrDyn can help.

Whether you need to supplement existing technology teams with specialist expertise or launch a data program that lays the groundwork for future internal hires, you can partner with Corrdyn to unlock the potential of your business data - today. 

Visit connect.corrdyn.com/biotech to learn more.

Data in Biotech is a fortnightly podcast exploring how companies leverage data innovation in life sciences.

This week, we’re delighted to be joined by Jesse Johnson, Founder of Merelogic, a consultancy service for biotech startups who want to get their data under control so they can focus on the science.

Host Ross Katz speaks with Jesse about the importance of data in biotech startups, the challenges of bridging the gap between biologists and data scientists, the need for more modular and customizable data tools, and the potential for automation and AI in biotech research.

---

If you’re a biotech company struggling to unlock a data challenge, CorrDyn can help.

Whether you need to supplement existing technology teams with specialist expertise or launch a data program that lays the groundwork for future internal hires, you can partner with Corrdyn to unlock the potential of your business data - today. 

Visit connect.corrdyn.com/biotech to learn more.

Data in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences. 

This week, we're delighted to be joined by Tommy Tang, Director of Computational Biology at Immunitas Therapeutics - an immuno-oncology therapeutics company advancing multiple programs to the clinic.

Host Ross Katz speaks with Ming “Tommy” Tang about the scalability of the cloud and its impact on improving biotech data, Keeping data in-house vs. big data warehouses (and the messiness of public data), where ML should best play in computational biology and so much more. 

---

If you’re a biotech company struggling to unlock a data challenge, CorrDyn can help.

Whether you need to supplement existing technology teams with specialist expertise or launch a data program that lays the groundwork for future internal hires, you can partner with Corrdyn to unlock the potential of your business data - today. 

Visit connect.corrdyn.com/biotech to learn more.

Data in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences. 

This week, we're delighted to be joined by Miguel Cacho Soblechero, Ph.D., a senior data scientist at Prolaio - a biotech company that integrates clinical research and data science to improve research, access and outcomes for people with heart conditions.

Host Ross Katz speaks with Miguel on the lessons learned transitioning from a Ph.D. into the data science industry of biotechnology, the problems with the current state of data in clinical trials, and the massive opportunity to improve clinical trials with data, AI, machine learning to sift through electronic health records, and how wearable technology is the future for better patient engagement. 

---

If you’re a biotech company struggling to unlock a data challenge, CorrDyn can help.

Whether you need to supplement existing technology teams with specialist expertise or launch a data program that lays the groundwork for future internal hires, you can partner with Corrdyn to unlock the potential of your business data - today. 

Visit connect.corrdyn.com/biotech to learn more.

This week, we're delighted to be joined by Michelle Wiest, Director of IVD Biostatistics at Freenome - a high-growth biotech company that creates tools to help prevent, detect, and treat disease.

Host Ross Katz speaks with Michelle on the use of biostatistics in the field of diagnostics, what biases can corrupt diagnostic tests and how to catch them early, the different types of data sets that are being used to develop diagnostic models and how to prepare to present data to regulatory bodies such as the FDA.

---

If you’re a biotech company struggling to transform your business with data, CorrDyn can help.

Whether you need to supplement existing technology teams with specialist expertise or launch a data program that lays the groundwork for future internal hires, you can partner with Corrdyn to unlock the potential of your business data - today. 

Visit connect.corrdyn.com/biotech to learn more. 

---

Data in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences. 

This week, we're delighted to be joined by Markus Gershater, Chief Scientific Officer and CoFounder of Synthace - a digital experiment platform built for high-performance life science R&D teams to help them run more powerful experiments and accelerate scientific progress. 

Host Ross Katz speaks with Markus on what’s broken about:

• What’s broken about how laboratories across the globe run biological experiments at scale
• The opportunity that exists for researchers in striving to achieve experimental design automation processes
• Why, as an industry, we must move towards implementing infrastructure that enables multifactorial experiments versus one-factor experiments
• And the role of AI in making sense of complex systems. 

---

If you’re a biotech company struggling to transform your business with data, CorrDyn can help.

Whether you need to supplement existing technology teams with specialist expertise or launch a data program that lays the groundwork for future internal hires, you can partner with Corrdyn to unlock the potential of your business data - today. 

Visit connect.corrdyn.com/biotech to learn more. 

---

Data in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences.